Evidence map›Paper›PMID 42277894›Full record

ArticleOrphanet journal of rare diseases2026

Exploring a cherubism bone phenotype outside the craniofacial region.

Anne Morice, Philippe Drabent, Sylvie Thomasseau, Aline Joly, Gérard Maruani, Marie Piketty, Séverine Brabant, Jeanne Amiel, Arnaud Picard, Natacha Kadlub and 1 more

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anne MoriceService de chirurgie maxillo-faciale et plastique de la face, CHRU de Tours, Hôpital Clocheville, Centre de compétence MAFACE et CRANIOST, Tours, 37044, France.
Philippe DrabentPathology Department, Necker-Enfants Malades Hospital, APHP, Paris, France.
Sylvie ThomasseauBIOSCAR, INSERM U1132, Université de Paris Cité, Hôpital Lariboisière, Paris, 75010, France.
Aline JolyService de chirurgie maxillo-faciale et plastique de la face, CHRU de Tours, Hôpital Clocheville, Centre de compétence MAFACE et CRANIOST, Tours, 37044, France.
Gérard MaruaniInstitut Necker Enfants-Malades, INSERM U1151 - CNRS UMR 8253, Université Paris Cité, Paris, France.
Marie PikettyAPHP, Necker Enfants Malades, Service des Explorations Fonctionnelles, Paris, 75015, France.
Séverine BrabantAPHP, Necker Enfants Malades, Service des Explorations Fonctionnelles, Paris, 75015, France.
Jeanne AmielDépartement de Génétique, Hôpital Necker-Enfants Malades, Institut Imagine, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
Arnaud PicardAPHP, Necker Enfants Malades, Service de Chirurgie Maxillo-faciale et Plastique, Paris, 75015, France.
Natacha Kadlub *APHP, Necker Enfants Malades, Service de Chirurgie Maxillo-faciale et Plastique, Paris, 75015, France. natacha.kadlub@aphp.fr.
Amélie E Coudert *BIOSCAR, INSERM U1132, Université de Paris Cité, Hôpital Lariboisière, Paris, 75010, France. amelie.coudert@inserm.fr.ORCID 0000-0002-4644-5449

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cherubism is a rare paediatric bone disease caused by gain-of-function mutations in the SH3BP2 gene. This condition is characterized by osteolysis of the jaw bone, which can be sometimes massive, whereby bone is replaced by fibrous tissue containing osteoclast-like multinucleated giant cells. Recently, a patient with a severe cherubism was reported to have, in addition to the craniofacial cherubism features, a low bone mass phenotype. To determine whether this patient was the exception or the rule, the cherubism phenotype was explored in ten more patients outside the cranio-facial. For the first time, inflammatory and bone blood markers together with bone density and growth in height and weight were systematically assessed in relation to the radiological and NFATc1 location classifications. We observed normal weight and height in the patients, as well as a significant increase in the bone metabolism blood markers (especially CTx and P1NP), which was associated with the severity of the cherubism. Our analysis also highlights the need for more systematic assessments of cherubism patients to improve our understanding of the cherubism natural history.

Indexed as

CherubismAdaptor Proteins, Signal TransducingBone DensityChildFemaleHumansMaleNFATC Transcription FactorsPhenotypeAdaptor Proteins, Signal TransducingNFATC Transcription FactorsSH3BP2 protein, humanBlood markersBone densityCherubismNFATc1

Identifiers

PMID42277894
PMCPMC13487941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.